Press Release

Dendritic Cell Vaccine

One year after his last treatment, a six-year-old boy with recurrent neuroblastoma is in complete remission for his high-risk metastaticcancer. Doctors reported this case study in the January 2013 issue of Pediatrics, the journal of the American Academy of Pediatrics.

Read More